首页> 中文期刊> 《中外医疗 》 >低分子肝素钙联合法舒地尔治疗短暂性脑缺血发作的可行性分析

低分子肝素钙联合法舒地尔治疗短暂性脑缺血发作的可行性分析

             

摘要

目的:对低分子肝素钙联合法舒地尔治疗短暂性脑缺血发作的可行性进行分析与探讨。方法选取2012年5月—2014年4月在该院接受治疗的短暂性脑缺血发作患者100名,以随机方式将其平均分为两组,即对照组与观察组,对对照组患者实施血塞通粉剂、拜阿司匹林及胞二磷胆碱治疗,对观察组患者实施盐酸法舒地尔、低分子肝素钙及胞二磷胆碱治疗,对两组患者治疗效果进行分析与对比。结果对照组患者治疗有效率为70.0%,观察组患者治疗有效率为96.0%,两组患者治疗有效率差异比较明显,观察组优于对照组,差异有统计学意义(P<0.05)。结论法舒地尔联合低分子肝素能够有效治疗短暂性脑缺血发作,值得临床应用与推广。%Objective The purpose of the low molecular weight heparin combined with fasudil feasibility transient ischemic therapy were analyzed and discussed. Methods 100 May 2012-April 2014 in our hospital for treatment of patients with transient cerebral ischemia, in a random manner which were divided into two groups, namely the control group and the observation group, fold the implementation of the control group patients he Division Ting, Xuesetong powders, aspirin and citicoline treatment, the number of the observation group were implemented fasudil hydrochloride, low molecular weight heparin and citicoline treatment, the treatment effect of two groups of patients analysis and comparison. Results treating patients in the control group was 70.0% in the observa-tion group was 98.0% in patients with a therapeutically effective, efficient treatment groups were more obvious differences, the ob-servation group than the control group, P <0.05, statistically significant. Conclusion The study shows that fasudil LMWH can be effective in treating transient cerebral ischemia, worthy of clinical application and promotion.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号